Истории Proteomics

https://www.inomixo.com/omics-services-and-cro-solutions-for-biomedical%20-discovery-research.html Biomedical Discovery Research Proteomics plays a pivotal role in early drug research, offering unparalleled efficiency and accuracy in target identification. Through comprehensive analysis of protein expression variances between drug-treated and control groups, coupled with advanced bioinformatics, proteomics unveils the impact of drugs on cellular physiology. This deep understanding aids in elucidating drug utility and mechanisms of action. Moreover, proteomics facilitates target discovery by effectively isolating drug-interacting proteins through competitive experiments. Leveraging mass spectrometry, proteomics enables the identification of target proteins-a feat unattainable through conventional biological methods. Beyond target identification, proteomics delves into the intricate web of drug-target interactions, shedding light on their influence on protein-protein interactions.

SILAC Proteomics Analysis silac Stable isotope labeling with amino acids https://www.creative-proteomics.com/services/silac-based-proteomics-analysis.htm

https://www.inomixo.com/services/spatial-omics/ What Is Spatial Omics? Spatial omics enables scientists to explore the spatial distribution and interactions of biomolecules, such as genes, proteins, metabolites, and more, at the tissue or cellular level. These spatial omics technologies, including spatial transcriptomics, spatial proteomics, spatial metabolomics, among others, provide a finer resolution insight into complex biological systems. Based on the spatial omics database, they unveil molecular signatures of cell-cell interactions, tissue architecture, and functional zones, offering a deeper understanding of biological phenomena. INOMIXO Spatial Omics As one of the leading spatial omics companies, INOMIXO offers single-cell proteomics for detecting gene expression in individual cells, as well as multiplexed tissue imaging technology for enabling comprehensive phenotypic profiling and spatial analysis of the tissue microenvironment.

https://www.inomixo.com/services/tmt-tandem-mass-tag-proteomics.html The tmt based quantitative proteomics technology is a relative and absolute quantification technique for peptide-based proteomics. It utilizes 6, 10, or 16 isotopic labels to specifically label the amino groups of peptides. Through tmt tandem mass tag spectrometry analysis, it enables the simultaneous comparison of protein expression levels across up to 16 different samples. TMT labeling is a high-throughput screening technique widely used in quantitative proteomics research. TMT based Proteomics Workflow Uniform processing of samples labeled in the same batch reduces sample handling and experimental errors, resulting in high experimental reproducibility. High quantitative stability is achieved when samples are labeled in the same batch. The use of fractionation methods significantly increases the depth of protein identification. TMT Proteomics Provides Distinct Advantages Over iTRAQ Quantitative Accuracy:TMT Offers higher quantitative accuracy and precision due to improved isotopic purity and reduced interference.

https://www.inomixo.com/services/4d-dia-proteomics-service/ Conventional proteomics research relies on three dimensions post proteolytic digestion: retention time, mass-to-charge ratio (m/z), and peptide ion intensity. With the development of Trapped Ion Mobility Spectrometry (TIMS) and Parallel Accumulation Serial Fragmentation (PASEF) techniques, ion mobility dimension was added as the forth separation dimension, making 4D proteomics technology the latest quantitative approach. Based on Bruker timsTOF Pro2 platform, 4D DIA Proteomics significantly improves the scanning speed and detection sensitivity, as well as enhances 4D astral proteomics analysis performance in terms of identification depth and quantitative accuracy with less sample input. The Optimal Choice for 4D Proteomics Analysis of Large-Cohort Samples 4D Proteomics High Sensitivity: Nearly 100% ion utilization, greatly improving detection sensitivity. Deeper Protein Identification: Protein identification level has increase by 20%, 6000+ cells per needle (200 ng 293T cells). Higher integrity and reproducibility of protein area. Smaller Sample Size Required: Suitable for rare and minimal samples: FFPE, tissue biopsies, immune cells...... 4D-DIA Proteomics Project Workflow.

On behalf of the Scientific Committee, we are honored to invite you to 12th International Conference and Expo on Proteomics and Molecular Medicine to be held in Dublin, Ireland during November 26-28, 2018. The Theme of the Proteomics and Molecular Medicine 2018 is "Solving problems in Proteomics, Biology and Medicine" which covers wide range of critically important sessions in the field of Proteomics, Molecular Medicine, Mass Spectrometry, Protein Analysis, Biochemistry, Bioinformatics, Molecular Diagnostics, Molecular Devices, Molecular Biology and Pathology. Objective of this meeting is to share the foremost updated knowledge in the field of proteomics, drug discovery, development and diagnostics. We will gather academicians and young inspired scientists from all around the world involved in researches at the cutting edge in the study of the proteomics and molecular medicine. The conference proceedings will include Keynote/plenary Sessions, Oral Presentations, Seminars, Symposiums, Workshops, Young Researchers Forums and Posters Presentations on the latest treatment innovations in the field of Molecular Medicine, Diagnostics and the advancements in Proteomics, Bioinformatics and Mass spectrometry, Cardiac Proteomics by experts from both academic and business background. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Proteomics and Molecular Medicine.

https://www.inomixo.com/services/4d-dia-proteomics-service/ Conventional astral proteomics research relies on three dimensions post proteolytic digestion: retention time, mass-to-charge ratio (m/z), and peptide ion intensity. With the development of Trapped Ion Mobility Spectrometry (TIMS) and Parallel Accumulation Serial Fragmentation (PASEF) techniques, ion mobility dimension was added as the forth separation dimension, making 4D proteomics technology the latest quantitative approach.